AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AZTherapies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11231
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D for the early prevention of Alzheimer’s disease; and ALZT-OP1a, to treat post stroke cognitive impairment (PSCI). ALZT-OP1 is a combination therapy consisting of two re-engineered drugs, in which drug A inhibits beta-amyloid peptide polymerization, and lowers cytokine production, while drug B inhibits the neuroinflammatory response. AZTherapies is headquartered in Boston, Massachusetts, the US.

AZTherapies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AZTherapies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AZTherapies Raises USD7.7 Million in Venture Financing 10
AZTherapies Raises Additional USD8.4 Million in Venture Financing 11
AZTherapies Raises USD1.6 Million in Venture Financing 12
AZTherapies Raises Additional USD2.9 Million in Venture Financing 13
AZTherapies Raises USD3.6 Million in Venture Financing 14
AZTherapies Raises Additional USD2.3 Million in Venture Financing 15
AZTherapies Raises USD13.8 Million in Venture Financing 16
AZTherapies Raises USD6 Million in Venture Financing 17
AZTherapies Inc – Key Competitors 18
AZTherapies Inc – Key Employees 19
AZTherapies Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Oct 31, 2017: AZTherapies appoints Karen Reeves, MD as President and Chief Medical Officer 21
Clinical Trials 22
Jan 31, 2018: A new publication confirms AZTherapies’s innovative drug combination approach to address the neuroinflammation response via neuro-immunology and amyloid beta accumulation associated with neurodegeneration and Alzheimer’s disease 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
AZTherapies Inc, Pharmaceuticals & Healthcare, Key Facts 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AZTherapies Raises USD7.7 Million in Venture Financing 10
AZTherapies Raises Additional USD8.4 Million in Venture Financing 11
AZTherapies Raises USD1.6 Million in Venture Financing 12
AZTherapies Raises Additional USD2.9 Million in Venture Financing 13
AZTherapies Raises USD3.6 Million in Venture Financing 14
AZTherapies Raises Additional USD2.3 Million in Venture Financing 15
AZTherapies Raises USD13.8 Million in Venture Financing 16
AZTherapies Raises USD6 Million in Venture Financing 17
AZTherapies Inc, Key Competitors 18
AZTherapies Inc, Key Employees 19

List of Figures
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AZTherapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務分析
    Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report Summary Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Navamedic ASA (NAVA):企業の財務・戦略的SWOT分析
    Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Louis Dreyfus Company B.V.:企業の戦略的SWOT分析
    Louis Dreyfus Company B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Advanced Biological Laboratories SA-製薬・医療分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Vanguard Natural Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Vanguard Natural Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Vanguard Natural Resources, Inc (Vanguard) is an independent oil and gas company with upstream operations. It acquires, produces, and develops oil and natural gas properties. The compa …
  • Seiko Optical Products Co Ltd:企業の戦略的SWOT分析
    Seiko Optical Products Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • SmarTone Telecommunications Holdings Ltd (315):企業の財務・戦略的SWOT分析
    SmarTone Telecommunications Holdings Ltd (315) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Engepack Embalagens SA:企業の戦略・SWOT・財務情報
    Engepack Embalagens SA - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Svelte Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Svelte Medical Systems Inc (Svelte) is a medical device company that manufactures and designs balloon expandable stents. The company offers products such as balloon expandable stents, svelte acrobat, and drug eluting stents, among others. Its svelte acrobat is a stent-on-a-wire bare metal co …
  • Tosoh Corp (4042):企業の財務・戦略的SWOT分析
    Tosoh Corp (4042) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Neuraltus Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. It develops macrophage which is based on the recent und …
  • Bengal Energy Ltd (BNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets in Australia’s Cooper Basin and India’s Cauvery Basin. The company holds interest in Toooko …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Insightra Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Cathe …
  • EBN B.V.:石油・ガス:M&Aディール及び事業提携情報
    Summary EBN BV (EBN) is an independent oil and natural gas company that carries out exploration, production, storage and trading of oil and natural gas. The company participates in nearly all the exploration and production activities in the Netherlands through a public-private partnership model. It …
  • NXT Energy Solutions Inc (SFD):石油・ガス:M&Aディール及び事業提携情報
    Summary NXT Energy Solutions Inc (NXT Energy), formerly Energy Exploration Technologies Inc is an oilfield service company that offers geophysical services to the upstream oil and gas industry. The company provides Stress Field Detection (SFD) a patent pending gravity-based instrument that provides …
  • AutoCanada Inc.:企業のM&A・事業提携・投資動向
    AutoCanada Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AutoCanada Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • California Resources Corp (CRC):企業の財務・戦略的SWOT分析
    California Resources Corp (CRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BSN medical GmbH:医療機器:M&Aディール及び事業提携情報
    Summary BSN medical GmbH (BSN medical), a subsidiary of Essity Aktiebolag, is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases and lumphology, and non-invasive orthopedic produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆